Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …

Objective To determine the risk of pre-eclampsia associated with factors that may be present
at antenatal booking. Design Systematic review of controlled studies published 1966-2002 …

Growing evidence suggests that thrombophilia is associated with venous thromboembolism
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …

Antiphospholipid syndrome, a condition characterized by one or more thrombotic or
pregnancy-related clinical features in association with medium to high levels of …

BACKGROUND: The association between antiphospholipid antibodies (APLA) and placenta
mediated pregnancy complications (pre-eclampsia, intrauterine growth restriction (IUGR) …

There are multiple epidemiological studies that document the potential adverse affects of
autoimmunity on nearly every aspect of reproduction, even in the absence of clinically …

METHODS OF STUDY SELECTION: Inclusion criteria were: cohorts, case-control, or
controlled cross-sectional studies; healthy pregnancy as controls; no autoimmune diseases; …

Citation Ahn H, Park J, Gilman‐Sachs A, Kwak‐Kim J. Immunologic characteristics of
preeclampsia, a comprehensive review. Am J Reprod Immunol 2011; 65: 377–394 …

Antiphospholipid syndrome (APS) is associated with adverse pregnancy outcomes including
preeclampsia, recurrent early pregnancy loss, fetal death, and intrauterine growth restriction …

Worldwide, pre-eclampsia and eclampsia contribute to the death of a pregnant woman every
3 min. In the UK in recent decades, hypertensive disorders of pregnancy have remained one …